JAK-STAT Signaling in Diseases

Regular price €173.60
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
Activate JAK2
advanced cell signaling research
Atopic dermatitis
Category=PSB
cytokine receptors
Cytokine signalling
Diabetes and Obesity
EASI Score
eq_bestseller
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
Ferm Domain
hematopoiesis mechanisms
immune system regulation
inflammatory disease pathways
Jak Inhibitor
Jak Mutation
Jak Protein
Jak Stat Activation
Jak Stat Pathway
Jak Stat Signaling
Jak Stat Signaling Pathway
JAK2 Inhibitor
JAK2 STAT3 Pathway
JAK2 V617F
JAK2 V617F Mutation
MicroRNA mediated regulation
Organ Transplantation
Pia Protein
RPE Cell
SH2 Domain
signal transduction
Stat Family Member
Stat Inhibitor
Stat Protein
Stat Signaling
STAT1 Activation
STAT1 Deficient Mouse
STAT6 Mutation
STAT6 siRNA
Targeting Jak-STATs
translational medicine

Product details

  • ISBN 9781138487628
  • Weight: 771g
  • Dimensions: 178 x 254mm
  • Publication Date: 12 Mar 2020
  • Publisher: Taylor & Francis Ltd
  • Publication City/Country: GB
  • Product Form: Hardback
Secure checkout Fast Shipping Easy returns

JAK-STAT pathway is one of the few signal transduction pathways that transduce signals involved in multiple homeostatic biological processes including cell differentiation and proliferation, cell death, hematopoiesis and immune responses. JAK-STAT is an elegant pathway that is relatively simple and evolutionary conserved as gene expression is regulated by external parameters. Activated by growth factors or cytokines, this signal transduction cascade regulates the transcription of genes at the nucleus. Mutations and polymorphisms in JAK-STAT pathway are associated with inflammatory diseases and cancers that could impede regular homeostasis.

Features:

  • Details activation and microRNA-mediated regulation of JAK-STAT pathway
  • Provides exclusive information about the association of the pathway in various diseases including allergic inflammation, neuro-inflammatory disorder, atopic dermatitis hematopoietic malignancies, cardiovascular disorder, renal disorder, immunodeficiency, liver fibrosis, diabetes and obesity that affect individuals across the globe
  • Clinical relevance of the signaling cascade has been discussed in context of novel class of therapeutics that targets this pathway.

An overview of JAK-STAT signaling pathway and the structure-function relationship of different domains of the cascade are discussed. This book provides detailed information on various diseases that are associated with JAK-STAT pathway. It will act as a very good reference book for basic science researchers, academicians, industry professionals involved in translational research leading to product development. This book will excite future professionals towards better understanding of the regulation of this pathway, its association with other signaling cascades to design novel therapeutics.

Ritobrata Goswami, PhD is presently working as an Assistant Professor in the School of Bioscience, IIT Kharagpur since 2016. Prior to his present affiliation, Dr Goswami was associated with the Division of Biological and Life Sciences, Ahmedabad University (2014-16). He received his bachelor (2005) and masters degree (2007) in Biotechnology from West Bengal University of Technology and Birla Institute of Technology & Science, Pilani; respectively. Dr Goswami obtained his PhD at Indiana University, Indianpolis, USA (2012) followed by post-doctoral training at the Icahn School of Medicine at Mount Sinai, New York, USA (2012-14). He is a life member of the Indian Immunology Society. Dr Goswami has extramural projects funded by the Government of India. Dr Goswami’s research interests include the role of nutrients and hormones in the development and function of T helper cells to regulate inflammatory disorders. He is keen on identifying a regulating network of transcription factors involved in autoimmune and inflammatory disorders so that better therapeutics can be developed.